These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J7316

  Injection, ocriplasmin, 0.125 mg

• J7318

  Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg

• J7320

  Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg

• J7321

  Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose

• J7322

  Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg

• J7323

  Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose

• J7324

  Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose

• J7325

  Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg

• J7326

  Hyaluronan or derivative, gel-one, for intra-articular injection, per dose

• J7327

  Hyaluronan or derivative, monovisc, for intra-articular injection, per dose

• J7328

  Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg

• J7329

  Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg

• J7330

  Autologous cultured chondrocytes, implant

• J7331

  Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg

• J7332

  Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg

• J7333

  Hyaluronan or derivative, visco-3, for intra-articular injection, per dose

• J7335

  Capsaicin 8% patch, per 10 square centimeters

• J7336

  Capsaicin 8% patch, per square centimeter

• J7340

  Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml

• J7342

  Instillation, ciprofloxacin otic suspension, 6 mg

• J7345

  Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg

• J7351

  Injection, bimatoprost, intracameral implant, 1 microgram

• J7352

  Afamelanotide implant, 1 mg

• J7353

  Anacaulase-bcdb, 8.8% gel, 1 gram

• J7354

  Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)

• J7355

  Injection, travoprost, intracameral implant, 1 microgram

• J7356

  Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg

• J7401

  Mometasone furoate sinus implant, 10 micrograms

• J7402

  Mometasone furoate sinus implant, (sinuva), 10 micrograms

• J7500

  Azathioprine, oral, 50 mg

• J7501

  Azathioprine, parenteral, 100 mg

• J7502

  Cyclosporine, oral, 100 mg

• J7503

  Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg

• J7504

  Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg

• J7505

  Muromonab-cd3, parenteral, 5 mg

• J7506

  Prednisone, oral, per 5 mg

• J7507

  Tacrolimus, immediate release, oral, 1 mg

• J7508

  Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg

• J7509

  Methylprednisolone oral, per 4 mg

• J7510

  Prednisolone oral, per 5 mg

• J7511

  Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg

• J7512

  Prednisone, immediate release or delayed release, oral, 1 mg

• J7513

  Daclizumab, parenteral, 25 mg

• J7514

  Mycophenolate mofetil (myhibbin), oral suspension, 100 mg

• J7515

  Cyclosporine, oral, 25 mg

• J7516

  Injection, cyclosporine, 250 mg

• J7517

  Mycophenolate mofetil, oral, 250 mg

• J7518

  Mycophenolic acid, oral, 180 mg

• J7519

  Injection, mycophenolate mofetil, 10 mg

• J7520

  Sirolimus, oral, 1 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.